Compass Therapeutics CMPX
NASDAQ CMPX
$2.38 +0.01 (+0.21%)
As of: Sep 4, 2026 · 2:36 PM EDT

Compass Therapeutics (CMPX) Property, Plant & Equipment (Net) (2019 - 2026)

Analysis

Compass Therapeutics (CMPX) Property, Plant & Equipment (Net) (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.04 Bn 44.04 Bn - 34.61 Mn
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn - -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn 107.22 Mn
10 Compass Therapeutics 442.72 Mn 442.72 Mn - 324,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 324,000.00
Mar 31, 2026 169,000.00
Dec 31, 2025 102,000.00
Sep 30, 2025 119,000.00
Jun 30, 2025 131,000.00
Mar 31, 2025 102,000.00
Dec 31, 2024 353,000.00
Sep 30, 2024 493,000.00
Jun 30, 2024 592,000.00
Mar 31, 2024 744,000.00
Dec 31, 2023 898,000.00
Sep 30, 2023 1.05 Mn
Jun 30, 2023 1.20 Mn
Mar 31, 2023 1.37 Mn
Dec 31, 2022 1.57 Mn
Sep 30, 2022 1.71 Mn
Jun 30, 2022 1.85 Mn
Mar 31, 2022 2.14 Mn
Dec 31, 2021 2.24 Mn
Sep 30, 2021 1.44 Mn